950160.KQ
Kolon TissueGene, Inc.
KOE · Healthcare · Biotechnology · US
KRW 16,910.00
−5.53%Margins
Gross margin
8.0%
EBITDA margin
-2526.8%
EBIT margin
-507.4%
Net margin
-3811.2%
FCF margin
-1296.1%
-88.5%
Return on equity
-35.2%
Return on assets
-9.0%
Return on invested capital
0.01x
Asset turnover
-KRW 17.4B
Cash from operations
KRW 1.2K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026